Should HIV discordant couples have access to assisted reproductive technologies?

Journal of Medical Ethics

Volumn 29, Issue 6, 2003, Pages 325-329

  Spriggs, M ^a   Charles, T ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD WELFARE; CONCEPTION; DISEASE TRANSMISSION; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT EDUCATION; PATIENT SELECTION; PUBLIC HEALTH; RISK ASSESSMENT;

GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH;

CHILD; CHILD WELFARE; COSTS AND COST ANALYSIS; FEMALE; FERTILIZATION IN VITRO; HEALTH PERSONNEL; HIV SEROPOSITIVITY; HUMANS; MALE; PREJUDICE; RISK FACTORS;

EID: 0346265969     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.29.6.325     Document Type: Article

References (39)

1. Gilling-Smith C, Smith RJ, Semprini AE. [editorial], HIV and infertility: time to treat. BMJ 2001;322:566-7.
2. Englert Y, Van Vooren JP, Place I, et al. ART in HIV infected couples. Hum Reprod 2001;6:1309-15.
3. Semprini AE, Levi-Setti P, Bozzo, M, et al. Insemination of HIV negative women with processed semen of HIV positive partners. Lancet 1992;340:1317-19.
4. Wilde J. Conception in HIV discordant couples. World Federation of Hemophilia. Treatment of Hemophilia Monograph Series. http://www.wfh.org/Content_Documents/TOH_Monographs/TOH26_HIV- discordant_couples.pdf and follow links for the index (accessed 3 Sept 2003).
5. ASRM (American Society for Reproductive Medicine) Ethics Committee. Human immunodeficiency virus and infertility treatment. Fertil Steril 2002;77:218-22.
6. Anonymous. HIV 1 infection and artificial insemination with processed semen. MMWR Morb Mortal Wkly Rep 1990;39:249-56.
7. Baker HWG, Mijch A, Garland S, et al. Use of ART to reduce the risk of transmission in HIV discordant couples wishing to have their own children: male seropositive with undetectable viral load. J Med Ethics 2003;29:315-20.
8. Drapkin Lyerly A, Anderson J. Human immunodeficiency virus and assisted reproduction: reconsidering evidence, reframing ethics. Fertil Steril 2001;75:843-58.
9. Morris S. Clinics urged to tighten checks after embryo mix up. The Guardian 2002 Jul 10. http://www.guardian.co.uk/medicine/story/0,11381,751983,00.html (accessed 15 Jul 2002).
10. Dyer C. Black father identified in IVF mix up. The Guardian 2002 Aug 1. http://www.guardian.co.uk/race/story/0,11374,767242,00.html (accessed 5 Aug 2002).
11. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997;349:1294.
12. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
13. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
14. Centers for Disease Control and Prevention. US Public Health Service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV 1 for maternal health and for reducing perinatal HIV 1 transmission in the United States. MMWR Morb Mortal Wkly Rep 1998;47:1-30.
15. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-9.
16. Olaitan A, Reid W, Mocroft A, et al. Infertility among human immunodeficiency virus positive women: incidence and treatment dilemmas. Hum Reprod 1996;11:2793-6.
17. Politch JA, Mayer KH, Abbott AF, et al. The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seroposititve men. Fertil Steril 1994;61:922-8.
18. Crittenden JA, Handelsman DJ, Stewart GJ. Semen analysis in human immunodeficiency virus infection. Fertil Steril 1992;57:1294-9.
19. Muller CH, Coombs RW, Krieger JN. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1 seropositive men. Andrologia 1998;30:15-22.
20. Haas RH. A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Ann NY Acad Sci 2000;918:247-61.
21. Brinkman K, ter Hofstede HJ, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998;12:1735-44.
22. Marchione M. Does having a fatal disease rule out parenthood? Milwaukee Journal Sentinel 2002 Mar 11. www.jsonline.com/alive/column/mar02/26389.asp (accessed 5 Aug 2002).
23. Olivero OA, Fernandez JJ, Antiochos BB, et al. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in erythrocebus patas monkeys. J Acquir Immune Defic Syndr 2002;29:323-9.
24. Steinbock B, McClamrock R. When is birth unfair to the child? Hastings Cent Rep 1994;24:15-21.
25. Infertility Treatment Act 1995. Act no 63/1995. Version No 016. kttp://www.dms.dpc.vic.gov.au/ (accessed 3 Sept 2003).
26. Human Fertilisation and Embryology Act 1990. (c 37). http://www.hmso.gov.uk/acts/acts1990/Ukpga_19900037_en_1.htm (accessed 24 Sept 2002).
27. Harris J. The value of life. London: Routledge, 1985:154.
28. Pohlman E. The psychology of birth planning. Cambridge: Schenkman Publishing Company, Inc, 1969:48-81.
29. Harris J. Rights and reproductive choice. In: Harris J, Holm S, eds. The future of human reproduction: ethics, choice, and regulation. Oxford: Clarendon Press, 1998:5-37.
30. Gray D. Enforced baby classes ruled out. The Age 2002 Aug 27;news:4.
31. Wallace R. Backdown on parent class plan. Herald Sun 2002 Aug 27;news:4.
32. State Government, Victoria, Australia. Disability on line: information for people with a disability, their families, and carers. Birth defects involving chromosomes - trisomy disorders. http://www.disability.vic.gov.au/dsonline/dsarticles.nsf/pages/ Birth_defects_involving_chromosomes (accessed 5 Aug 2002).
33. Lo W, Friedman J. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002;100:465-73.
34. Spriggs M. Ethical implications of women's under representation in clinical trials. Monash Bioeth Rev 1999;18(suppl):11-20S.
35. Hansen M, Kurinczuk J, Bower C, et al. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilisation. N Engl J Med 2002;346:725-30.
36. Brown J, Chapman S, Lupton D. Infinitesimal risk as public health crisis: news media coverage of a doctor patient HIV contact tracing investigation. Soc Sci Med 1996;43:1685-95.
37. Fuscaldo G. Fatherless families: how important is genetic relatedness? Monash Bioeth Rev 2002;21:18-29.
38. Stern J, Cramer C, Garrod A, et el. Access to services at assisted reproductive technology clinics: a survey of policies and practices. Am J Obstet Gynecol 2001;184:591-7.
39. Smith S. The fertility race: HIV and fertility. http://americanradioworks.org/features/fertility_race/ (accessed 5 Aug 2002).